Aisha Hasan

1.3k total citations
55 papers, 696 citations indexed

About

Aisha Hasan is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Aisha Hasan has authored 55 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 28 papers in Immunology and 25 papers in Epidemiology. Recurrent topics in Aisha Hasan's work include CAR-T cell therapy research (27 papers), Cytomegalovirus and herpesvirus research (25 papers) and Immune Cell Function and Interaction (12 papers). Aisha Hasan is often cited by papers focused on CAR-T cell therapy research (27 papers), Cytomegalovirus and herpesvirus research (25 papers) and Immune Cell Function and Interaction (12 papers). Aisha Hasan collaborates with scholars based in United States, Netherlands and Canada. Aisha Hasan's co-authors include Richard J. O’Reilly, Guenther Koehne, Susan E. Prockop, Ekaterina Doubrovina, Annamalai Selvakumar, R J O'Reilly, Wouter J.W. Kollen, Deepa Trivedi, Thomas J. Matthews and Karen L. Wilson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aisha Hasan

50 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aisha Hasan United States 14 367 257 226 136 123 55 696
Francesca Mazzetta Italy 17 208 0.6× 480 1.9× 210 0.9× 133 1.0× 160 1.3× 21 863
Dilani Dombagoda United States 5 372 1.0× 270 1.1× 186 0.8× 72 0.5× 98 0.8× 8 579
W. Herr Germany 19 282 0.8× 507 2.0× 192 0.8× 84 0.6× 194 1.6× 32 846
Joseph P. Balint United States 18 235 0.6× 395 1.5× 111 0.5× 173 1.3× 174 1.4× 35 753
Mieke Sprangers Germany 10 138 0.4× 139 0.5× 96 0.4× 257 1.9× 186 1.5× 13 551
Roelof A. de Paus Netherlands 16 274 0.7× 627 2.4× 201 0.9× 117 0.9× 173 1.4× 27 923
Emily S.J. Edwards Australia 15 264 0.7× 628 2.4× 132 0.6× 132 1.0× 185 1.5× 37 993
Renate de Boer Netherlands 16 576 1.6× 654 2.5× 167 0.7× 199 1.5× 187 1.5× 30 1.1k
Hideki Ohminami Japan 15 412 1.1× 514 2.0× 177 0.8× 90 0.7× 283 2.3× 18 920
Dimitra Zotos Australia 13 180 0.5× 1.2k 4.6× 112 0.5× 63 0.5× 173 1.4× 16 1.4k

Countries citing papers authored by Aisha Hasan

Since Specialization
Citations

This map shows the geographic impact of Aisha Hasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha Hasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha Hasan more than expected).

Fields of papers citing papers by Aisha Hasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisha Hasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha Hasan. The network helps show where Aisha Hasan may publish in the future.

Co-authorship network of co-authors of Aisha Hasan

This figure shows the co-authorship network connecting the top 25 collaborators of Aisha Hasan. A scholar is included among the top collaborators of Aisha Hasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisha Hasan. Aisha Hasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hasan, Aisha, et al.. (2023). Impact of Donor, Recipient, and Graft Characteristics on Corneal Transplantation Outcomes. Clinical ophthalmology. Volume 17. 633–640. 1 indexed citations
3.
4.
Gupta, Mrinali P., Ekaterina Doubrovina, Aisha Hasan, et al.. (2021). Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes. Ophthalmology Retina. 5(9). 838–849. 14 indexed citations
5.
Iqbal, Nadeem, et al.. (2020). Telemedicine in Urology Clinic in COVID Era and the Inherent Challenges in Developing Countries: Review Article. 9(11). 1–3. 3 indexed citations
6.
Iqbal, Nadeem, et al.. (2020). Utility of Telemedicine in Pediatric Urology Clinic duringCovid-19 Era-Mini Review. 10(2). 57–61. 3 indexed citations
7.
Naveed, Abdul Khaliq, et al.. (2020). Association of single nucleotide polymorphism of transforming growth factor beta1 (T29C) in breast cancer patients: a case control study in Rawalpindi. Journal of the Pakistan Medical Association. 70(0). 1–1. 1 indexed citations
8.
Rapoport, Aaron P., James E. Hoffman, Jonathan L. Kaufman, et al.. (2020). Open-label pilot study of genetically engineered NY-ESO-1–specific t cells (GSK3377794) alone or in combination with pembrolizumab in relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 38(15_suppl). TPS8555–TPS8555. 3 indexed citations
9.
O’Reilly, Richard J., Susan E. Prockop, Aisha Hasan, & Ekaterina Doubrovina. (2019). Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction. Bone Marrow Transplantation. 54(S2). 759–764. 13 indexed citations
10.
Ahmed, Mahiuddin, Andrés López‐Albaitero, Dmitry Pankov, et al.. (2018). TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI Insight. 3(4). 34 indexed citations
11.
Iqbal, Nadeem, et al.. (2018). Clinicopathological Characteristics Of Prostate Cancer In Patients Presenting To A Tertiary Care Private Sector Hospital. Journal of College of Physicians And Surgeons Pakistan. 28(5). 409–411. 3 indexed citations
12.
Prockop, Susan E., Ekaterina Doubrovina, Aisha Hasan, et al.. (2016). Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant. Blood. 128(22). 61–61. 5 indexed citations
13.
O’Reilly, R.J., et al.. (2015). T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells. Bone Marrow Transplantation. 50(S2). S43–S50. 11 indexed citations
14.
Hupert, Nathaniel, et al.. (2015). Optimizing Health Care Coalitions: Conceptual Frameworks and a Research Agenda. Disaster Medicine and Public Health Preparedness. 9(6). 717–723. 7 indexed citations
15.
Koehne, Guenther, et al.. (2015). Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia. Biology of Blood and Marrow Transplantation. 21(9). 1663–1678. 73 indexed citations
16.
O’Reilly, Richard J., Aisha Hasan, Ekaterina Doubrovina, Guenther Koehne, & Susan E. Prockop. (2011). Novel strategies for adoptive therapy following HLA disparate transplants. Best Practice & Research Clinical Haematology. 24(3). 381–391. 7 indexed citations
17.
Mahler, Michelle, Aisha Hasan, & James B. Bussel. (2010). Rituximab Maintenance Treatment In Immune Mediated Thrombocytopenia (ITP) Including Evans Syndrome. Blood. 116(21). 2523–2523. 1 indexed citations
18.
Hasan, Aisha, Annamalai Selvakumar, Ekaterina Doubrovina, et al.. (2009). Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies.. PubMed. 8(43). 210–8. 7 indexed citations
19.
Dwyer, John J., Karen L. Wilson, Aisha Hasan, et al.. (2008). Design of an engineered N‐terminal HIV‐1 gp41 trimer with enhanced stability and potency. Protein Science. 17(4). 633–643. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Mazzetta Breakdown of academic impact, for papers by Dilani Dombagoda Breakdown of academic impact, for papers by W. Herr Breakdown of academic impact, for papers by Joseph P. Balint Breakdown of academic impact, for papers by Mieke Sprangers Breakdown of academic impact, for papers by Roelof A. de Paus Breakdown of academic impact, for papers by Emily S.J. Edwards Breakdown of academic impact, for papers by Renate de Boer Breakdown of academic impact, for papers by Hideki Ohminami Breakdown of academic impact, for papers by Dimitra Zotos
Rankless by CCL
2026